Piramal (Germany)

Recent papers from Piramal (Germany)

1. Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [68Ga]Ga-RM2—A Head-to-Head Pilot Comparison with [68Ga]Ga-PSMA-11Cancers · 2023
2. PI-2620 Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer’s Disease and Other TauopathiesJournal of Medicinal Chemistry · 2021
3. 68Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [68Ga]Ga-RM2Pharmaceutics · 2021
4. Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohortScientific Reports · 2020
5. Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathiesEuropean Journal of Nuclear Medicine and Molecular Imaging · 2019
6. The Characterization of 18F-hGTS13 for Molecular Imaging of xC− Transporter Activity with PETJournal of Nuclear Medicine · 2019
7. A phase 1, first-in-human study of 18F-GP1 positron emission tomography for imaging acute arterial thrombosisEJNMMI Research · 2019
8. AMYPAD Diagnostic and Patient Management Study: Rationale and designAlzheimer s & Dementia · 2018
9. Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic reviewAlzheimer s Research & Therapy · 2018
10. Glycoprotein IIb/IIIa Receptor Imaging with¹⁸F-GP1 PET for Acute Venous Thromboembolism: An Open-Label, Nonrandomized, Phase 1 StudyJournal of Nuclear Medicine · 2018
11. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic CohortJAMA Neurology · 2018
12. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without DementiaJAMA Psychiatry · 2017
13. Validation of Noninvasive Tracer Kinetic Analysis of ¹⁸F-Florbetaben PET Using a Dual–Time-Window Acquisition ProtocolJournal of Nuclear Medicine · 2017
14. Added value of ¹⁸F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic studyAlzheimer s & Dementia · 2017
15. 18F-Florbetaben PET beta-amyloid binding expressed in CentiloidsEuropean Journal of Nuclear Medicine and Molecular Imaging · 2017
16. 18 F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of ThrombiJournal of Nuclear Medicine · 2017
17. Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18F-Florbetaben PETJournal of Nuclear Medicine · 2017
18. Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and designAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017
19. Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessmentNeuroImage Clinical · 2017
20. Advances in Aβ Plaque Detection and the Value of Knowing: Overcoming Challenges to Improving Patient Outcomes in Alzheimer’s DiseaseNeurodegenerative Disease Management · 2016